MedPath

to know the effect of dexamethasone on blood glucose concentration.

Phase 4
Conditions
Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecifiedHealth Condition 2: N00-N99- Diseases of the genitourinary system
Registration Number
CTRI/2023/07/055255
Lead Sponsor
kunal prasad gupta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1-patients posted for elective laparoscopic hysterectomy under general anaesthesia

2-ASA physical status 1 and 2

3-non-diabetic

Exclusion Criteria

1-patient refusal

2-history of allergy to the study drug

3-pregnancy

4-renal/hepatic disease

5-immunocompromised patients

6-patients on steroids therapy

7-duration of anaesthesia more than 4hours

8-history of peptic ulcer disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood glucose level in fasting and postprandialTimepoint: Blood glucose estimations (FBS)in 2hour 4hourand 6hour after giving single dose of dexamethasone <br/ ><br>again FBS and PPBS blood sugar estimations in POD1,POD2 AND POD3
Secondary Outcome Measures
NameTimeMethod
post operative nausea & vomiting upto POD1 <br/ ><br>post operative analgesics drug requirement upto POD1 <br/ ><br>observation of wound healing upto POD3Timepoint: blood glucose level upto 72 hours
© Copyright 2025. All Rights Reserved by MedPath